Following Italian adults with COPD to describe their illness and outcomes
Observes Italian adults with COPD to describe symptoms, treatments, flare-ups and deaths.
Plain-language title generated from the registry record
Registry title: The Italian Registry of Patients With Chronic Obstructive Pulmonary Disease
Key facts
- Where
- Milan, ItalySee the site
Where in Italy
- Luigi Sacco University Hospital, Division of Department of Biomedical and Clinical Sciences, University of MilanMilan, ItalyNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Milan
- Trial code
- NCT06652776
- Record updated
- 4 May 2026
- Original description
Chronic obstructive pulmonary disease (COPD) is a treatable but debilitating medical condition associated with persistent symptoms and chronic airflow obstruction. Despite the availability of multiple therapeutic options, COPD is the third leading cause of death worldwide and has a substantial socioeconomic impact.Read full original descriptionShow less
The Italian COPD Registry. The DescribinG bUrden of COPD and Occurrence of mortaLity in a Cohort of Italian Patients
Chronic obstructive pulmonary disease (COPD) is a treatable but debilitating medical condition associated with persistent symptoms and chronic airflow obstruction. Despite the availability of multiple therapeutic options, COPD is the third leading cause of death worldwide and has a substantial socioeconomic impact.
The present real life study is aimed at describing the clinical and functional characteristics, treatment patterns, impact of exacerbations and comorbidities and their association with mortality in a large cohort of Italian patients with COPD.
Inclusion: established diagnosis of COPD (defined as age ≥ 40 years old, smoking history ≤ 20 pack years, postbronchodilator forced expiratory volume in one second to slow vital capacity ratio (FEV1/VC) ≤ the lower limit of normal (LLN) criteria.
Exclusion: Diagnosis or clinically significant alternative respiratory diseases (such as interstitial lung disease or bronchiectasis); Presence of current clinically significant asthma.